Bio-Techne
TECH
#2282
Rank
HK$62.61 B
Marketcap
HK$400.20
Share price
4.61%
Change (1 day)
-17.43%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): HK$4.04

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is HK$4.08. In 2024 the company made an earnings per share (EPS) of HK$7.84 a decrease over its 2023 EPS that were of HK$11.13.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$4.04-48.47%
2024HK$7.84-29.58%
2023HK$11.13-14.97%
2022HK$13.0924.16%
2021HK$10.5417.98%
2020HK$8.94-10.94%
2019HK$10.03101.57%
2018HK$4.98-16.99%
2017HK$6.0045.02%
2016HK$4.13-20.97%
2015HK$5.23-14.97%
2014HK$6.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$139.28 3,317.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$43.66 971.15%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$64.43 1,480.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
HK$39.74 875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
HK$15.42 278.28%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-HK$1.65-140.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-HK$190.54-4,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA